Noel A. Warfel

2.3k total citations
39 papers, 1.7k citations indexed

About

Noel A. Warfel is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Noel A. Warfel has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Oncology and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Noel A. Warfel's work include Cancer Mechanisms and Therapy (16 papers), Peptidase Inhibition and Analysis (12 papers) and Cancer-related Molecular Pathways (6 papers). Noel A. Warfel is often cited by papers focused on Cancer Mechanisms and Therapy (16 papers), Peptidase Inhibition and Analysis (12 papers) and Cancer-related Molecular Pathways (6 papers). Noel A. Warfel collaborates with scholars based in United States, United Kingdom and Malaysia. Noel A. Warfel's co-authors include Wafik S. El‐Deiry, Andrew S. Kraft, Rachel K. Toth, Alexandra C. Newton, Phillip A. Dennis, David T. Dicker, M. Christine Hollander, Junji Tsurutani, Joell J. Gills and Alva G. Sainz and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Noel A. Warfel

39 papers receiving 1.7k citations

Peers

Noel A. Warfel
Christine M. Chresta United Kingdom
Ran Zhao United States
Bingbing Dai United States
Ramzi M. Mohammad United States
Jiancheng Hu China
Wei Cui United States
Annalisa Petrelli Italy
Helena Pópulo Portugal
Wilberto Nieves‐Neira United States
Ronald B. Gartenhaus United States
Christine M. Chresta United Kingdom
Noel A. Warfel
Citations per year, relative to Noel A. Warfel Noel A. Warfel (= 1×) peers Christine M. Chresta

Countries citing papers authored by Noel A. Warfel

Since Specialization
Citations

This map shows the geographic impact of Noel A. Warfel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noel A. Warfel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noel A. Warfel more than expected).

Fields of papers citing papers by Noel A. Warfel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noel A. Warfel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noel A. Warfel. The network helps show where Noel A. Warfel may publish in the future.

Co-authorship network of co-authors of Noel A. Warfel

This figure shows the co-authorship network connecting the top 25 collaborators of Noel A. Warfel. A scholar is included among the top collaborators of Noel A. Warfel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noel A. Warfel. Noel A. Warfel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liou, Hope, Lauren E. Ball, Jennifer R. Bethard, et al.. (2023). PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion. The Journal of Cell Biology. 222(6). 10 indexed citations
2.
Deshmukh, Sachin Kumar, Sharon Wu, Joanne Xiu, et al.. (2023). Characterizing the role of PIM kinases in the prostate tumor immune microenvironment.. Journal of Clinical Oncology. 41(16_suppl). e17080–e17080. 1 indexed citations
3.
Torres‐Ayuso, Pedro, Meghri Katerji, Venkata R. Sabbasani, et al.. (2023). PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer. Cell chemical biology. 31(2). 326–337.e11. 6 indexed citations
4.
Chauhan, Shailender S., Hope Liou, David F. Kashatus, et al.. (2023). PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer. Oncogene. 43(6). 406–419. 14 indexed citations
5.
Chauhan, Shailender S., Rachel K. Toth, Alva G. Sainz, et al.. (2021). Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors. Oncogene. 40(32). 5142–5152. 22 indexed citations
6.
Chauhan, Shailender S., et al.. (2020). PIM kinases alter mitochondrial dynamics and chemosensitivity in lung cancer. Oncogene. 39(12). 2597–2611. 43 indexed citations
7.
Gard, Jaime M.C., Mengdie Wang, James P. Hinton, et al.. (2019). Gene Editing of α6 Integrin Inhibits Muscle Invasive Networks and Increases Cell–Cell Biophysical Properties in Prostate Cancer. Cancer Research. 79(18). 4703–4714. 9 indexed citations
8.
Song, Jin H., Neha Singh, Sathish K.R. Padi, et al.. (2018). Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase. Molecular Cancer Therapeutics. 17(12). 2710–2721. 38 indexed citations
9.
Toth, Rachel K., Alva G. Sainz, Neha Singh, et al.. (2017). Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents. Clinical Cancer Research. 24(1). 169–180. 43 indexed citations
10.
Warfel, Noel A., Alva G. Sainz, Jin H. Song, & Andrew S. Kraft. (2016). PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species. Molecular Cancer Therapeutics. 15(7). 1637–1647. 44 indexed citations
11.
Zhang, Shengliang, Lanlan Zhou, Bo Hong, et al.. (2015). Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53. Cancer Research. 75(18). 3842–3852. 92 indexed citations
12.
Warfel, Noel A. & Andrew S. Kraft. (2015). PIM kinase (and Akt) biology and signaling in tumors. Pharmacology & Therapeutics. 151. 41–49. 153 indexed citations
13.
Warfel, Noel A. & Wafik S. El‐Deiry. (2014). HIF-1 Signaling in Drug Resistance to Chemotherapy. Current Medicinal Chemistry. 21(26). 3021–3028. 91 indexed citations
14.
Warfel, Noel A., Nathan G. Dolloff, David T. Dicker, Jozef Malysz, & Wafik S. El‐Deiry. (2013). CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth. Cell Cycle. 12(23). 3689–3701. 84 indexed citations
15.
Warfel, Noel A. & Wafik S. El‐Deiry. (2012). p21WAF1 and tumourigenesis. Current Opinion in Oncology. 25(1). 52–58. 243 indexed citations
16.
17.
Warfel, Noel A. & Alexandra C. Newton. (2011). Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase (PHLPP): A New Player in Cell Signaling. Journal of Biological Chemistry. 287(6). 3610–3616. 61 indexed citations
18.
19.
Brognard, John, Matthew J. Niederst, Gloria Reyes, Noel A. Warfel, & Alexandra C. Newton. (2009). Common Polymorphism in the Phosphatase PHLPP2 Results in Reduced Regulation of Akt and Protein Kinase C. Journal of Biological Chemistry. 284(22). 15215–15223. 34 indexed citations
20.
Gills, Joell J., Jaclyn LoPiccolo, Junji Tsurutani, et al.. (2007). Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo. Clinical Cancer Research. 13(17). 5183–5194. 264 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine M. Chresta Breakdown of academic impact, for papers by Ran Zhao Breakdown of academic impact, for papers by Bingbing Dai Breakdown of academic impact, for papers by Ramzi M. Mohammad Breakdown of academic impact, for papers by Jiancheng Hu Breakdown of academic impact, for papers by Wei Cui Breakdown of academic impact, for papers by Annalisa Petrelli Breakdown of academic impact, for papers by Helena Pópulo Breakdown of academic impact, for papers by Wilberto Nieves‐Neira Breakdown of academic impact, for papers by Ronald B. Gartenhaus
Rankless by CCL
2026